Syndax Pharmaceuticals
在场
高管
查看带有其 17 名主要高管的组织结构图
Syndax Pharmaceuticals 搜索最多的简介
- Michael Metzger, Director and Chief Executive Officer
- Jennifer Jarrett, Director
- Pierre Legault, Director
高管在Syndax Pharmaceuticals变化
- Aleksandra Rizo已作为Director加入公司 (新闻发布的2024五月16号).
- Steve Sabus, Chief Commercial Officer, 已经离开公司 (新闻发布的2024三月24号).
- Steven Closter已作为Chief Commercial Officer加入公司 (新闻发布的2024三月24号).
创建提醒
跟踪 Syndax Pharmaceuticals 的高管变动
药店
Syndax Pharmaceuticals 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Syndax Pharmaceuticals 的最新新闻稿
- Syndax Announces Participation at Stifel Healthcare Conference | Syndax Pharmaceuticals, Inc.
- Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update | Syndax Pharmaceuticals, Inc.
- Syndax and Incyte Announce Positive Topline Results from the Pivotal AGAVE-201 Trial of Axatilimab in Chronic Graft-Versus-Host Disease | Syndax Pharmaceuticals, Inc.
- Syndax to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast on August 3, 2023 | Syndax Pharmaceuticals, Inc.
- Syndax to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 8, 2022 | Syndax Pharmaceuticals, Inc.
- Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | Syndax Pharmaceuticals, Inc.
- Syndax Pharmaceuticals Announces Appointment of Keith A. Goldan as Chief Financial Officer | Syndax Pharmaceuticals, Inc.
- Syndax Announces Participation at Two Upcoming Investor Conferences | Syndax Pharmaceuticals, Inc.
- Syndax Announces Participation at Citi's Biopharma Virtual Co-Panel Day | Syndax Pharmaceuticals, Inc.
- Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update | Syndax Pharmaceuticals, Inc.
- View more press releases Close
通过电子邮件
